Cogent Biosciences (COGT) Competitors $4.98 -0.33 (-6.21%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$5.06 +0.08 (+1.61%) As of 05/21/2025 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock COGT vs. MIRM, APLS, ARWR, VCEL, NAMS, GMTX, AAPG, BLTE, HRMY, and DNLIShould you be buying Cogent Biosciences stock or one of its competitors? The main competitors of Cogent Biosciences include Mirum Pharmaceuticals (MIRM), Apellis Pharmaceuticals (APLS), Arrowhead Pharmaceuticals (ARWR), Vericel (VCEL), NewAmsterdam Pharma (NAMS), Gemini Therapeutics (GMTX), Ascentage Pharma Group International (AAPG), Belite Bio (BLTE), Harmony Biosciences (HRMY), and Denali Therapeutics (DNLI). These companies are all part of the "pharmaceutical products" industry. Cogent Biosciences vs. Mirum Pharmaceuticals Apellis Pharmaceuticals Arrowhead Pharmaceuticals Vericel NewAmsterdam Pharma Gemini Therapeutics Ascentage Pharma Group International Belite Bio Harmony Biosciences Denali Therapeutics Cogent Biosciences (NASDAQ:COGT) and Mirum Pharmaceuticals (NASDAQ:MIRM) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their community ranking, valuation, earnings, analyst recommendations, institutional ownership, dividends, profitability, media sentiment and risk. Which has more volatility & risk, COGT or MIRM? Cogent Biosciences has a beta of 1.91, suggesting that its stock price is 91% more volatile than the S&P 500. Comparatively, Mirum Pharmaceuticals has a beta of 0.95, suggesting that its stock price is 5% less volatile than the S&P 500. Do analysts recommend COGT or MIRM? Cogent Biosciences presently has a consensus price target of $14.00, suggesting a potential upside of 181.12%. Mirum Pharmaceuticals has a consensus price target of $60.73, suggesting a potential upside of 37.05%. Given Cogent Biosciences' higher possible upside, analysts clearly believe Cogent Biosciences is more favorable than Mirum Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cogent Biosciences 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.75Mirum Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 10 Buy rating(s) 2 Strong Buy rating(s) 3.17 Does the MarketBeat Community favor COGT or MIRM? Cogent Biosciences received 155 more outperform votes than Mirum Pharmaceuticals when rated by MarketBeat users. However, 76.40% of users gave Mirum Pharmaceuticals an outperform vote while only 70.12% of users gave Cogent Biosciences an outperform vote. CompanyUnderperformOutperformCogent BiosciencesOutperform Votes29170.12% Underperform Votes12429.88% Mirum PharmaceuticalsOutperform Votes13676.40% Underperform Votes4223.60% Which has stronger valuation & earnings, COGT or MIRM? Mirum Pharmaceuticals has higher revenue and earnings than Cogent Biosciences. Mirum Pharmaceuticals is trading at a lower price-to-earnings ratio than Cogent Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCogent BiosciencesN/AN/A-$192.41M-$1.84-2.71Mirum Pharmaceuticals$379.25M5.79-$163.41M-$1.61-27.52 Does the media refer more to COGT or MIRM? In the previous week, Mirum Pharmaceuticals had 12 more articles in the media than Cogent Biosciences. MarketBeat recorded 18 mentions for Mirum Pharmaceuticals and 6 mentions for Cogent Biosciences. Mirum Pharmaceuticals' average media sentiment score of 1.32 beat Cogent Biosciences' score of 1.28 indicating that Mirum Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cogent Biosciences 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Mirum Pharmaceuticals 11 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is COGT or MIRM more profitable? Cogent Biosciences has a net margin of 0.00% compared to Mirum Pharmaceuticals' net margin of -31.69%. Mirum Pharmaceuticals' return on equity of -41.22% beat Cogent Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Cogent BiosciencesN/A -112.55% -60.44% Mirum Pharmaceuticals -31.69%-41.22%-14.81% SummaryMirum Pharmaceuticals beats Cogent Biosciences on 11 of the 16 factors compared between the two stocks. Get Cogent Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for COGT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart COGT vs. The Competition Export to ExcelMetricCogent BiosciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$567.00M$6.49B$5.36B$8.39BDividend YieldN/A2.66%5.22%4.10%P/E Ratio-2.018.9426.5919.72Price / SalesN/A251.55391.61116.20Price / CashN/A65.8538.2534.62Price / Book2.176.466.794.51Net Income-$192.41M$143.98M$3.23B$248.18M7 Day Performance2.05%3.16%4.03%1.14%1 Month Performance15.81%7.60%12.22%15.07%1 Year Performance-37.12%-2.36%16.76%6.59% Cogent Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)COGTCogent Biosciences2.3621 of 5 stars$4.98-6.2%$14.00+181.1%-37.1%$567.00MN/A-2.0180News CoveragePositive NewsAnalyst ForecastGap DownMIRMMirum Pharmaceuticals4.0844 of 5 stars$44.89-0.3%$60.73+35.3%+71.8%$2.22B$379.25M-22.22140Positive NewsAnalyst ForecastAnalyst RevisionAPLSApellis Pharmaceuticals4.1686 of 5 stars$17.67+1.3%$40.42+128.8%-59.1%$2.22B$775.84M-8.70770ARWRArrowhead Pharmaceuticals3.5161 of 5 stars$15.74+0.2%$42.13+167.6%-38.8%$2.17B$545.21M-3.04400Positive NewsAnalyst ForecastGap UpVCELVericel2.5561 of 5 stars$42.54+0.1%$60.86+43.1%-20.3%$2.14B$238.54M709.12300Positive NewsNAMSNewAmsterdam Pharma2.5095 of 5 stars$19.03+0.8%$43.00+126.0%-5.0%$2.09B$47.14M-10.124Gap UpGMTXGemini TherapeuticsN/A$48.09+2.1%N/A+54.7%$2.08BN/A-48.0930High Trading VolumeAAPGAscentage Pharma Group InternationalN/A$23.78+5.0%N/AN/A$2.07B$980.65M0.00600Positive NewsBLTEBelite Bio2.0486 of 5 stars$65.00+0.9%$96.67+48.7%+48.2%$2.07BN/A-58.5610News CoverageAnalyst RevisionGap UpHRMYHarmony Biosciences4.7872 of 5 stars$35.91+2.4%$52.78+47.0%+16.4%$2.06B$744.85M17.02200Positive NewsDNLIDenali Therapeutics4.4182 of 5 stars$13.91+0.9%$33.71+142.4%-31.5%$2.02B$330.53M-5.04430Analyst Forecast Related Companies and Tools Related Companies Mirum Pharmaceuticals Alternatives Apellis Pharmaceuticals Alternatives Arrowhead Pharmaceuticals Alternatives Vericel Alternatives NewAmsterdam Pharma Alternatives Gemini Therapeutics Alternatives Ascentage Pharma Group International Alternatives Belite Bio Alternatives Harmony Biosciences Alternatives Denali Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:COGT) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredHow I profit during chaos…This Guy THRIVES on Chaos Wall Street legend Larry Benedict has thrived through every major market crash. I...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cogent Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cogent Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy COGT Stock Free COGT Stock Alerts